The DOI matches its Crossref record.
Intravenous levodopa in hallucinating Parkinson's disease patients: High‐dose challenge does not precipitate hallucinations
Abstract
In five nondemented Parkinson's disease patients with daily visual hallucinations, we tested whether high-dose IV levodopa (LD) infusions precipitated hallucinations. Two infusion paradigms were studied, each with 1.5-mg/kg hourly dose for 4 hours--steady infusion and pulse infusion of the full hour dose over 5 minutes each hour. In both protocols, plasma LD levels changed significantly during the infusion protocol. The cumulative area under the curve was equivalent for the two infusions. All patients remained alert, and none developed visual hallucinations. The two patients with peak-dose dyskinesias on oral LD developed prominent dyskinesias during the infusion. Visual hallucinations do not relate simply to high levels of LD or to sudden changes in plasma levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders · doi:10.1002/mds.21382 · Cited by 528
Self-citationCollerton, D., Perry, E., & McKeith, I. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000130 · Cited by 437
The psychosis spectrum in Parkinson disease
ffytche, D. H., Creese, B., Politis, M., Chaudhuri, K. R., Weintraub, D., Ballard, C., & Aarsland, D. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.200 · Cited by 355
Aarsland, D., Ballard, C., Larsen, J. P., & McKeith, I. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.389 · Cited by 358
Metadata
- Authors
- Goetz, C. G., Pappert, E. J., Blasucci, L. M., Stebbins, G. T., Ling, Z. D., Nora, M. V., & Carvey, P. M.
- Venue
- Neurology
- Published
- 1998-02
- Volume
- 50
- Issue
- 2
- Pages
- 515-517
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2137566057
- Cited by
- 170
- References
- 0
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous levodopa in hallucinating Parkinson's disease patients: High‐dose challenge does not precipitate hallucinations. https://app.cochat.ai/papers/10.1212/wnl.50.2.515
- The paper
- Goetz, C. G., Pappert, E. J., Blasucci, L. M., Stebbins, G. T., Ling, Z. D., Nora, M. V., & Carvey, P. M. (1998). Intravenous levodopa in hallucinating Parkinson's disease patients: High‐dose challenge does not precipitate hallucinations. Neurology. https://doi.org/10.1212/wnl.50.2.515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.